A company with a headquarters in one state and employees logging in from a dozen others cannot run drug testing the way it did when everyone worked from the same building. The single biggest mistake HR teams make is assuming their corporate policy travels with the company. It does not. In almost every situation, the law that governs a drug test is the law of the state where the employee actually performs the work, not the state where the company is incorporated or where its headquarters sits. Once that principle is understood, the rest of a remote and multi-state testing program is mostly logistics.
The State Where the Employee Works Controls, Not Headquarters
Employment law generally follows the worksite. For a remote employee, the worksite is the employee's home or wherever they are logging in from, not the office where their manager or the HR department sits. This matters because state drug testing statutes vary widely in what they require and what they prohibit. Some states, like Minnesota, have detailed statutory requirements for how an employer must notify employees of testing, what confirmation testing is required, and what an employee's rights are if a result is challenged. Minnesota's drug and alcohol testing statute lays out specific procedures employers must follow, including confirmatory testing and written policy notice requirements, and applies to employees working in that state regardless of where the employer is based. Florida, by contrast, ties its drug testing rules to a voluntary Drug-Free Workplace Program that offers workers' compensation premium discounts to employers who follow its procedures, a very different structure from Minnesota's mandatory framework.
A company headquartered in a state with light drug testing regulation but employing remote workers in a heavily regulated state cannot rely on its home-state comfort level. If an employee works from Minnesota, the employer needs to follow Minnesota's rules for that employee even if every other policy document says otherwise. This is why a single, one-size-fits-all national policy fails as soon as a company has employees in more than a handful of states.
Marijuana-Protected States vs. At-Will Testing States
The clearest fault line in multi-state drug testing right now is marijuana. A growing number of states have passed laws that limit an employer's ability to take adverse action against an employee for off-duty, off-premises cannabis use or for a positive marijuana test alone. California's AB 2188 amended the state's Fair Employment and Housing Act to prohibit discrimination against employees or applicants based on off-duty cannabis use away from the workplace, with the law generally protecting non-psychoactive metabolites found in urine and hair tests while still allowing employers to act on impairment at work. New York's adult-use cannabis law similarly restricts employers from testing for marijuana or disciplining employees for legal off-duty use, with narrow exceptions for safety-sensitive positions and situations required by federal law or contract. New York's Department of Labor publishes guidance for employers explaining how the cannabis law interacts with existing drug-free workplace policies.
At the other end of the spectrum are traditional at-will, zero-tolerance states where an employer can generally test for marijuana and take action on a positive result without the same off-duty use carve-outs, subject to any state-specific notice or procedural requirements like Minnesota's or Florida's. A multi-state employer with a workforce spread across both types of states cannot run one national marijuana policy. The same job title, the same test panel, and the same positive result can produce a lawful termination in one state and an unlawful adverse action in another.
| State approach | What it generally means | Example states |
|---|---|---|
| Off-duty use protected | Employer cannot discipline solely for a positive marijuana result or known off-duty legal use; impairment at work is still actionable | California, New York |
| Statute-driven procedural states | Testing is allowed but must follow detailed statutory notice, collection, and confirmation procedures | Minnesota |
| Voluntary program states | No blanket testing mandate; employers who opt into a state drug-free workplace program follow its specific rules for incentives like insurance discounts | Florida |
| Federally regulated, state law does not control | DOT and other federally mandated safety-sensitive testing overrides state marijuana protections | Applies nationwide to covered positions |
Safety-Sensitive and DOT-Covered Roles Are a Separate Track
State marijuana protections generally do not reach employees who are subject to federal drug testing rules. The Department of Transportation's drug and alcohol testing regulations, found in Title 49 of the Code of Federal Regulations, set collection, laboratory, and reporting procedures that apply uniformly across state lines to safety-sensitive transportation employees, including commercial drivers, pilots, and pipeline workers. The Federal Motor Carrier Safety Administration's rules for commercial drivers, found separately in Title 49 Part 382, define which positions are considered safety-sensitive and require pre-employment, random, post-accident, reasonable suspicion, and return-to-duty testing regardless of any state law protecting off-duty marijuana use. An employer with drivers based in a marijuana-protected state still tests those drivers under federal rules, because federal law preempts conflicting state protections for that category of work.
This creates a practical split inside a single company. Office-based remote employees in a protected state may fall under that state's marijuana limitations, while a driver, pilot, or other DOT-covered employee working from the same state does not get the benefit of those protections for marijuana specifically. Policies need to say this explicitly, position by position, rather than leaving managers to guess which employees are covered.
Collection Mechanics for a Distributed Workforce
Once the legal framework is sorted out, the operational question is how to actually collect a specimen from someone who does not come into an office. Three approaches cover most situations.
The first is a collection site network. National and regional laboratory networks maintain thousands of collection sites, and an employer can direct a remote employee to the nearest one for urine, oral fluid, or hair collection under standard chain-of-custody procedures. This preserves the strongest evidentiary chain because a trained collector handles the specimen from start to finish, but it depends on site availability near the employee and adds scheduling friction, especially in rural areas.
The second is an at-home observed or virtually observed collection. Some programs use a trained collector who conducts the collection remotely by video, watching the employee perform the collection according to a defined protocol. This works for situations where a physical site visit is not practical, but it requires a defensible protocol for identity verification, chain of custody documentation, and specimen security in transit, since the specimen has to be shipped or otherwise transferred after collection rather than handed directly to a collector.
The third is an oral fluid kit shipped to the employee for a supervised collection conducted over video call. This has become more common because oral fluid collection is simpler to observe remotely than a urine collection, and SAMHSA's mandatory guidelines for federal workplace drug testing using oral fluid, published in the Federal Register, establish the specimen validity and laboratory certification standards that make oral fluid testing scientifically defensible. Employers should understand the evidentiary limits before relying on this method for anything beyond routine, non-DOT screening. A shipped kit with remote video observation depends on stable video and internet connectivity, a collector who can clearly see the entire procedure, and a documented chain of custody once the sealed specimen leaves the employee's hands and enters a shipping carrier's system. If a court or arbitrator later challenges the result, gaps in any of those steps can undermine the test's defensibility in a way that an in-person collection at a certified site does not carry. For DOT-regulated employees, oral fluid testing must follow the specific procedures in Part 40 and cannot rely on an informal remote video setup. Employers building a remote testing program can source oral fluid and urine collection kits, supplies, and rapid test cups designed for supervised and lab-based collection through American Screening Corp's drug test collection.
| Collection method | Best fit | Evidentiary strength | Main limitation |
|---|---|---|---|
| Certified collection site network | Employees near a lab partner site; DOT-covered roles | Highest, trained collector handles full chain of custody | Site availability and scheduling in rural areas |
| At-home or virtual observed collection | Remote employees without nearby site access, non-DOT roles | Moderate to high, depends on protocol rigor | Requires documented identity verification and shipping chain of custody |
| Shipped oral fluid kit with video supervision | Routine pre-employment or periodic screening for distributed teams | Moderate, workable for non-regulated testing | Connectivity dependent; not a substitute for DOT-specified procedures |
One Policy, State-Specific Addenda
The structure most HR teams land on is a single core policy document that states the company's general drug-free workplace philosophy, the categories of testing it performs, and the consequences of a positive result, paired with short state-specific addenda that override or modify the core policy where state law requires it. The core document handles the parts that do not vary, like safety expectations, confidentiality of results, and the process for a Medical Review Officer to review a non-negative screen before it becomes final. The addenda handle the parts that do vary, such as advance written notice requirements, whether off-duty marijuana use alone can support discipline, and any state-mandated confirmation testing procedures like Minnesota's.
Practically, this means maintaining a short reference table internally that maps each state where the company has employees to the applicable addendum, and updating an employee's applicable addendum automatically when their listed work location changes. It also means training managers not to apply the "default" policy from habit when an employee in a protected state tests positive for marijuana, since that is exactly the scenario where a one-size-fits-all approach creates legal exposure. Reviewing how legalization has reshaped what employers can and cannot do is worth doing before finalizing addenda language, since the rules continue to shift state by state.
Frequently asked questions
Does the employer's headquarters state ever apply instead of the employee's work state?
Generally no. Courts and state agencies look at where the work is performed to determine which state's employment protections apply to an individual worker. A company can choose a governing law clause for certain contract disputes, but state drug testing statutes and marijuana employment protections are typically applied based on the employee's actual worksite, which for a remote employee is their home or remote work location.
Can a company still test remote employees for marijuana in a state that protects off-duty use?
In states like California and New York, an employer generally cannot take adverse action based solely on a positive marijuana result reflecting off-duty, off-premises use, though impairment at work and safety-sensitive job exceptions still apply. The company can still include marijuana on a test panel, but how it responds to a positive result needs to account for the state's protections rather than treating it the same as any other substance.
Do DOT drug testing rules apply to fully remote employees?
DOT testing rules under Title 49 CFR Part 40 apply to employees in safety-sensitive positions defined by the relevant DOT agency, not to remote status. A remote employee who does not perform safety-sensitive functions, such as driving a commercial vehicle, is not covered by DOT testing requirements simply because the company also employs drivers elsewhere.
Is a shipped oral fluid kit with video supervision legally sufficient for a pre-employment test?
For non-DOT, non-regulated pre-employment screening, many employers use shipped oral fluid kits with remote video observation as part of a documented protocol. The specimen validity testing standards that make oral fluid results defensible are set out in SAMHSA's mandatory guidelines. Employers should have written procedures for identity verification, observation, and chain of custody in transit, and should not use this method for DOT-covered positions, which require Part 40 procedures.
How often should a multi-state policy be reviewed?
There is no fixed schedule mandated by federal law, but a policy should be reviewed whenever the company adds employees in a new state, whenever a state where the company already has employees changes its drug testing or cannabis employment law, or whenever a position's safety-sensitive classification changes. Building the review into the same process that tracks new-state hiring approvals keeps the policy from going stale.
Further reading: Marijuana Legalization and Workplace Drug Testing: What Employers Can Still Do and DOT Oral Fluid Drug Testing in 2026: What Employers Need to Know.
This article is general information, not legal advice. Multi-state and remote employee drug testing policies should be reviewed by qualified employment counsel licensed in each state where the company has employees before adoption.
